Meyer Handelman Company’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.82M | Sell |
3,472
-522
| -13% | -$274K | 0.06% | 136 |
|
|
2025
Q1 | $2.53M | Sell |
3,994
-125
| -3% | -$79.3K | 0.09% | 125 |
|
|
2024
Q4 | $2.93M | Sell |
4,119
-141
| -3% | -$100K | 0.1% | 118 |
|
|
2024
Q3 | $4.48M | Sell |
4,260
-5
| -0.1% | -$5.26K | 0.15% | 107 |
|
|
2024
Q2 | $4.48M | Hold |
4,265
| – | – | 0.16% | 102 |
|
|
2024
Q1 | $4.11M | Hold |
4,265
| – | – | 0.14% | 110 |
|
|
2023
Q4 | $3.75M | Buy |
4,265
+30
| +0.7% | +$26.3K | 0.15% | 110 |
|
|
2023
Q3 | $3.49M | Buy |
4,235
+435
| +11% | +$358K | 0.14% | 114 |
|
|
2023
Q2 | $2.73M | Buy |
3,800
+225
| +6% | +$162K | 0.11% | 124 |
|
|
2023
Q1 | $2.94M | Buy |
3,575
+70
| +2% | +$57.5K | 0.12% | 118 |
|
|
2022
Q4 | $2.53M | Sell |
3,505
-150
| -4% | -$108K | 0.11% | 122 |
|
|
2022
Q3 | $2.52M | Buy |
3,655
+50
| +1% | +$34.4K | 0.12% | 121 |
|
|
2022
Q2 | $2.13M | Hold |
3,605
| – | – | 0.09% | 124 |
|
|
2022
Q1 | $2.52M | Buy |
3,605
+460
| +15% | +$321K | 0.1% | 125 |
|
|
2021
Q4 | $1.99M | Buy |
3,145
+175
| +6% | +$111K | 0.07% | 128 |
|
|
2021
Q3 | $1.8M | Hold |
2,970
| – | – | 0.07% | 127 |
|
|
2021
Q2 | $1.66M | Buy |
2,970
+725
| +32% | +$405K | 0.07% | 134 |
|
|
2021
Q1 | $1.06M | Buy |
+2,245
| New | +$1.06M | 0.04% | 146 |
|